Mannitol (D) USP For Compounding (API)

Mannitol (D) USP For Compounding (API) is a versatile pharmaceutical ingredient commonly used as an osmotic diuretic in medical formulations. It helps reduce intracranial pressure and intraocular pressure, making it essential in treatments for conditions like cerebral edema and glaucoma. Additionally, Mannitol is utilized as a renal function diagnostic aid and can be part of formulations for promoting urinary excretion in cases of renal failure. Due to its excellent solubility and stability, it also serves as an excipient in various compounded medications. Ensuring adherence to high-quality standards, this API supports optimized patient outcomes in fluid balance management, kidney health, and overall therapeutic interventions.

Mannitol (D) USP is an active pharmaceutical ingredient (API) used in the production of medications and medical products. It is a white crystalline powder derived from sugar and is classified as an osmotic diuretic. It is used in the treatment of conditions such as glaucoma, increased intracranial pressure, and oliguria (low urine output). Mannitol works by drawing fluid into the kidneys, increasing urine production and promoting the elimination of toxins from the body. It is manufactured and sold as per the standards set by the United States Pharmacopeia (USP). 

Mannitol (D) USP for compounding is a sugar alcohol that is used primarily as a sweetener and bulking agent in pharmaceutical compounding. It is a white, crystalline powder that is generally considered safe for human consumption. Mannitol is often used in the formulation of oral medications, as it helps to improve the taste, texture, and stability of the final product. In addition to its use as a sweetener, Mannitol also has diuretic properties and can be used to treat conditions such as cerebral edema and acute kidney injury.

CAS Number: 69-65-8